EFS

In cancer, the length of time after primary treatment for a cancer ends that the patient remains free of certain complications or events that the treatment was intended to prevent or delay. These events may include the return of the cancer or the onset of certain symptoms, such as bone pain from cancer that has spread to the bone. In a clinical trial, measuring the EFS is one way to see how well a new treatment works. Also called event-free survival. (NCI Dictionary)

YOU MAY ALSO LIKE

EFP Cell Cycle Pathway

The estrogen-inducible RING finger protein Efp stimulates proliferation of breast cancer cells. 14-3-3 is p53-inducible protein that sequesters mitotic Cdks in the…

EFNB2 wt Allele

Human EFNB2 wild-type allele is located in the vicinity of 13q33 and is approximately 45 kb in length. This allele, which encodes…

EFNB2 Gene

This gene is involved in cell-cell signaling.

Eflucimibe

A dodecylthio-phenylacetanilide derivative with hypocholesterolemic and anti-atherosclerotic properties. Eflucimibe is an inhibitor of acyl-Coenzyme A:cholesterol acyltransferase (ACAT), an intracellular enzyme which catalyzes…

Eflornithine Hydrochloride Ointment

An ointment formulation of the hydrochloride salt of an ornithine decarboxylase (ODC) inhibitor with hair-growth inhibitory and potential chemopreventive activities. When administered…

Eflornithine Hydrochloride

The hydrochloride form of eflornithine, a difluoromethylated ornithine compound with antineoplastic activity. Eflornithine irreversibly inhibits ornithine decarboxylase, an enzyme required for…